ArticleCell & bioscience2026
The molecular mechanism underlying the differential subcellular distribution of dystrophin Dp71 isoforms.
Article in Cell & bioscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundDystrophin Dp71 is a versatile protein that plays a critical role in regulating diverse processes, including cell adhesion, nuclear architecture, neuronal differentiation, and synapse organization. Moreover, Dp71 is involved in cognitive, retinal vascular and cancer diseases. This multifunctional role is believed to result from the alternative splicing undergoes by Dp71 transcript. As previously outlined, the splicing of exon 78 appears to influence the localization of Dp71 isoforms. Specifically, Dp71d, containing exon 78, shows nuclear localization, while Dp71f, lacking exon 78 and instead having 31 hydrophobic residues (founder sequence), shows cytoplasmic localization. We delineate the mechanism dictating the differential localization between Dp71 isoforms, using various reporter vectors, in combination with protein-protein interaction assays, site-directed mutagenesis on nuclear export signal (NES), knockdown experiments on importin α2 and CRM1 nuclear transporters, and molecular dynamic simulations.
resultsWe demonstrate that both Dp71d and Dp71f translocate to the nucleus via importin α2/β1, interact with nuclear proteins, and are exported through a shared NES in exon 77 (NES1). However, we identified and characterized a second NES (NES2) located at the founder sequence, that binds to the exportin CRM1 with higher affinity, and thereby drives efficient nuclear export of Dp71f.
conclusionsAlternative splicing at exon 78, generates an NES unique to Dp71f, which dictates subcellular localization and function of this isoform. As a result, Dp71f is efficiently exported and becomes predominantly cytoplasmic, whereas Dp71d, without this NES, is exported less efficiently and remains longer in the nucleus.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.